Molecular Subtype
Triple-Negative Breast Carcinoma
CI-CAN-00008567TNBCExplore in graph →
416 active trials3 approved drugs8 evidence items
Loading cancer entity…
Loading cancer entity…
Molecular Subtype
CI-CAN-00008567TNBCExplore in graph →
Provenance
Every source that supplied a code, alias, edge, observation or derived value, with the ingest runs involved.
| Source | License | Contributions | Ingest runs | Last retrieved |
|---|---|---|---|---|
| CIViC — Clinical Interpretation of Variants in Cancer civic | approved | Codes, Evidence, Source Records | ING-CIVIC-20260929-000001 | Sep 29, 2026, 02:13 AM UTC |
| EMA — European public assessment reports (centrally authorised medicines) ema | approved | Approvals | — | Sep 16, 2026, 05:01 AM UTC |
| MeSH — Medical Subject Headings (NLM) mesh | approved | Aliases, Codes, Source Records | ING-MESH-20260908-000001 | Sep 8, 2026, 01:02 PM UTC |
| NCI Thesaurus (NCIt) ncit-evs | approved | Aliases, Codes, Description, Hierarchy, Source Records | ING-NCITEVS-20260908-000001 | Sep 8, 2026, 09:44 AM UTC |
| openFDA — Drugs@FDA applications and drug labels (SPL) openfda | approved | Approvals | — | Sep 28, 2026, 04:05 AM UTC |
| PubMed (NCBI E-utilities) pubmed | approved | Literature Counts | ING-PUBMED-20260914-000001 | Sep 14, 2026, 03:00 AM UTC |
Identifiers
Every upstream identifier is kept with its match type; nothing is buried in JSON.
Names
| Alias | Type | Terminology | Language |
|---|---|---|---|
| TNBC | abbreviation | NCIt | en |
| Triple Negative Breast Neoplasms | mesh_heading | MeSH | en |
| Triple-Negative Breast Carcinoma | preferred | NCIt | en |
| Breast Cancer, Triple-Negative | synonym | MeSH | en |
| ER Negative PR Negative HER2 Negative Breast Cancer | synonym | MeSH | en |
| ER Negative PR Negative HER2 Negative Breast Neoplasms | synonym | MeSH | en |
| Triple-Negative Breast Cancer | synonym | NCIt | en |
Change history
Creation, updates, merges and ranking changes recorded for this entity.